AI
Tuesday, March 04, 2014 10:47:23 PM
ZLCS - Ohhh indeed she looks primed. Let's look at the technical & recent news etc to really determine if she's good here.
$1.51 at resistance or support, $1.52 plus/minus 0.13. A typical rally for her 51.7% (0.78 pts)<--BIG when she moves (really good). Seeing a 3 day strong bullish chart pattern (possible bottom). I would put her up for a target of $2.24 (short-term)- $2.47(intermediate). Her resistance..perhaps between $1.70 - $1.85 before hitting 1st target $2.24
Basic Chart:
Recent NEWS: On February 3, 2014, Mr. Jason Cole, Executive Vice President, Corporate Development and General Counsel, provided notice to Zalicus Inc. (the "Company") of his intention to resign from the Company effective as of March 5, 2014 to pursue a new career opportunity. (GOOD, changes is needed here to grow company IMO)
Zalicus Improves Balance Sheet, Focuses On Z944 Exalgo Royalties Monetized (GOOD)
ref. http://seekingalpha.com/article/1991781-zalicus-improves-balance-sheet-focuses-on-z944?source=yahoo
On February 3, 2014, Zalicus Inc. (ZLCS) filed a Form 8K announcing the sale of all rights to future royalties on sales of Exalgo at Mallinckrodt Inc. in return for $7.2 million in cash. Zalicus originally entered into a licensing agreement with Mallinckrodt for Exalgo, an extended release formulation of hydromorphone hydrochloride, in June 2009. Exalgo was approved for sale in the U.S. in March 2010 and launched by Mallinckrodt in April 2010. To date, Zalicus has received $16.0 million in royalties relating to sales of Exalgo at Mallinckrodt. In the fourth quarter 2013, royalties on Exalgo totaled $2.0 million to Zalicus.
Last Note: ER's coming up Mar 6 - Mar 10 (Est. by yahoo) Not confirmed from Earnings Whisper). I would wait after earning's report or take risk with a minimum (starter position) then add after earning's report. My opinion she's 95% EXCELLENT trade.
$1.51 at resistance or support, $1.52 plus/minus 0.13. A typical rally for her 51.7% (0.78 pts)<--BIG when she moves (really good). Seeing a 3 day strong bullish chart pattern (possible bottom). I would put her up for a target of $2.24 (short-term)- $2.47(intermediate). Her resistance..perhaps between $1.70 - $1.85 before hitting 1st target $2.24
Basic Chart:
Recent NEWS: On February 3, 2014, Mr. Jason Cole, Executive Vice President, Corporate Development and General Counsel, provided notice to Zalicus Inc. (the "Company") of his intention to resign from the Company effective as of March 5, 2014 to pursue a new career opportunity. (GOOD, changes is needed here to grow company IMO)
Zalicus Improves Balance Sheet, Focuses On Z944 Exalgo Royalties Monetized (GOOD)
ref. http://seekingalpha.com/article/1991781-zalicus-improves-balance-sheet-focuses-on-z944?source=yahoo
On February 3, 2014, Zalicus Inc. (ZLCS) filed a Form 8K announcing the sale of all rights to future royalties on sales of Exalgo at Mallinckrodt Inc. in return for $7.2 million in cash. Zalicus originally entered into a licensing agreement with Mallinckrodt for Exalgo, an extended release formulation of hydromorphone hydrochloride, in June 2009. Exalgo was approved for sale in the U.S. in March 2010 and launched by Mallinckrodt in April 2010. To date, Zalicus has received $16.0 million in royalties relating to sales of Exalgo at Mallinckrodt. In the fourth quarter 2013, royalties on Exalgo totaled $2.0 million to Zalicus.
Last Note: ER's coming up Mar 6 - Mar 10 (Est. by yahoo) Not confirmed from Earnings Whisper). I would wait after earning's report or take risk with a minimum (starter position) then add after earning's report. My opinion she's 95% EXCELLENT trade.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
